Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis

Wyeth

Status and phase: Completed; Phase 1

Conditions: Atrophic Vaginitis

Treatments: Drug: Premarin® oral tablets; Drug: Premarin® Vaginal Cream

Study type: Interventional

Funder types: Industry

Identifiers

NCT00167921

0713S5-414

Details and patient eligibility

About

The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with Premarin® oral tablets in postmenopausal women with atrophic vaginitis.

Sex: Female

Ages: 45 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Generally healthy postmenopausal women.
• Intact uterus.
• Clinical diagnosis of moderate to severe atrophic vaginitis.